IPO registrations (S-1, F-1) · Registrants
Scienture Holdings, Inc.
- SEC CIK
- 1382574 · filings on EDGAR ↗
- Former names
- TRxADE HEALTH, INC (2021–2024); TRXADE GROUP, INC. (2014–2021); XCELLINK INTERNATIONAL INC. (2008–2014); Bluebird Exploration Co. (2007–2008)
- Registration
- Form S-1, first filed 2019-05-06, last 2025-04-04; 7 initial registrations, 9 amendments
- Outcome
- Final prospectus filed 2020-02-14; declared effective 2019-07-01
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 20 AUSTIN BLVD., Commack, NY 11725
- Ticker
- SCNX (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Scienture Holdings, Inc. on the corporate pages
Offering terms
- Final price
- $7.50 per share (424B4 filed 2020-02-14)
- Shares sold
- 806,452
- Gross proceeds
- $6,048,390 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol MEDS
- Lead underwriters
- Dawson James (200,000 shares)
- Syndicate
- ViewTrade (184,616); of Contents; Dougherty & Company LLC (421,836)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: SCIENTURE HOLDINGS, INC. Fuzzy (name and state)
- Form D issuer: Scienture Holdings, Inc. EXACT (CIK (EXACT))
- SEC filer: Scienture Holdings, Inc. EXACT (CIK (EXACT))
Filings 28
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2019-05-06 | S-1 | S-1 (registration) | TRXADE GROUP, INC. | 0001493152-19-006486 ↗ |
| 2019-06-14 | S-1/A | S-1/A (amendment) | TRXADE GROUP, INC. | 0001493152-19-009221 ↗ |
| 2019-06-20 | S-1/A | S-1/A (amendment) | TRXADE GROUP, INC. | 0001493152-19-009510 ↗ |
| 2019-07-01 | EFFECT | EFFECT (declared effective) | TRXADE GROUP, INC. | 9999999995-19-001487 ↗ |
| 2019-10-15 | S-1 | S-1 (registration) | TRXADE GROUP, INC. | 0001493152-19-015539 ↗ |
| 2019-11-08 | S-1/A | S-1/A (amendment) | TRXADE GROUP, INC. | 0001493152-19-016686 ↗ |
| 2019-11-08 | EFFECT | EFFECT (declared effective) | TRXADE GROUP, INC. | 9999999995-19-002542 ↗ |
| 2019-12-17 | S-1 | S-1 (registration) | TRXADE GROUP, INC. | 0001493152-19-019311 ↗ |
| 2020-01-27 | S-1/A | S-1/A (amendment) | TRXADE GROUP, INC. | 0001493152-20-001110 ↗ |
| 2020-02-03 | S-1/A | S-1/A (amendment) | TRXADE GROUP, INC. | 0001493152-20-001484 ↗ |
| 2020-02-12 | S-1/A | S-1/A (amendment) | TRXADE GROUP, INC. | 0001493152-20-002062 ↗ |
| 2020-02-13 | EFFECT | EFFECT (declared effective) | TRXADE GROUP, INC. | 9999999995-20-000345 ↗ |
| 2020-02-14 | 424B4 | 424B4 (final prospectus) | TRXADE GROUP, INC. | 0001493152-20-002570 ↗ |
| 2020-09-03 | EFFECT | EFFECT (declared effective) | TRXADE GROUP, INC. | 9999999995-20-002361 ↗ |
| 2022-08-08 | EFFECT | EFFECT (declared effective) | TRxADE HEALTH, INC | 9999999995-22-002299 ↗ |
| 2022-11-28 | S-1 | S-1 (registration) | TRxADE HEALTH, INC | 0001493152-22-033832 ↗ |
| 2022-12-02 | EFFECT | EFFECT (declared effective) | TRxADE HEALTH, INC | 9999999995-22-003451 ↗ |
| 2023-04-17 | S-1 | S-1 (registration) | TRxADE HEALTH, INC | 0001493152-23-012620 ↗ |
| 2024-12-03 | S-1 | S-1 (registration) | Scienture Holdings, Inc. | 0001493152-24-048525 ↗ |
| 2025-01-14 | S-1/A | S-1/A (amendment) | Scienture Holdings, Inc. | 0001493152-25-001996 ↗ |
| 2025-01-30 | S-1/A | S-1/A (amendment) | Scienture Holdings, Inc. | 0001493152-25-004193 ↗ |
| 2025-02-06 | S-1/A | S-1/A (amendment) | Scienture Holdings, Inc. | 0001493152-25-005101 ↗ |
| 2025-02-14 | EFFECT | EFFECT (declared effective) | Scienture Holdings, Inc. | 9999999995-25-000459 ↗ |
| 2025-04-04 | S-1 | S-1 (registration) | Scienture Holdings, Inc. | 0001641172-25-002814 ↗ |
| 2025-04-11 | EFFECT | EFFECT (declared effective) | Scienture Holdings, Inc. | 9999999995-25-001097 ↗ |
| 2025-06-17 | EFFECT | EFFECT (declared effective) | Scienture Holdings, Inc. | 9999999995-25-001941 ↗ |
| 2025-08-08 | EFFECT | EFFECT (declared effective) | Scienture Holdings, Inc. | 9999999995-25-002543 ↗ |
| 2025-08-27 | EFFECT | EFFECT (declared effective) | Scienture Holdings, Inc. | 9999999995-25-002765 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-02-12 | S-1/A | registration statement | 806,452 | - | OTCQB TRXD | 3 | primary document; shares headline, cover names 3 | document ↗ | ||
| 2020-02-14 | 424B4 | final prospectus | $7.50 | 806,452 | $6,048,390 | Nasdaq MEDS | 4 | primary document; price line, shares headline, proceeds computed, underwriting table 3, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| POPE CHARLES L | Director | 4 | 2014–2022 | ||
| Ajjarapu Sandhya | TenPercentOwner | 1 | 2014 | ||
| AJJARAPU SURENDRA K | Director,Officer; Director,Officer,TenPercentOwner | CEO; Chairman and CEO; Chairman, CEO & Secretary | 11 | 2014–2024 | |
| Doss Howard A. | Officer; Other | CFO; Chief Financial Officer | 6 | 2014–2022 | |
| Fell Donald G. | Director | 14 | 2014–2022 | ||
| Patel Prashant | Director,Officer; Director,Officer,TenPercentOwner | CEO & President; Interim CFO and Director; President; President and COO | 9 | 2014–2024 | |
| Almeida Donald V. | Director | 1 | 2015 | ||
| PETERSON MICHAEL L | Director; Other | 10 | 2018–2023 | ||
| Augusta Gary | Director | 1 | 2019 | ||
| Tenaerts Pamela | Director; Other | 6 | 2019–2021 | ||
| Jennings Christine L. | Director | 2 | 2021 | ||
| Huffman Janet | Officer | CFO, PAO, PFO | 3 | 2022–2023 | |
| Newell A. Jeffrey | Director | 2 | 2022 | ||
| Narasimhan Mani | Director; Director,Officer | President & Co-CEO | 2 | 2024–2026 | |
| Shankar Hariharan | Director; Director,Officer,TenPercentOwner | Co-CEO & Chairman | 2 | 2024–2026 | |
| Sherb Eric Michael | Officer | Chief Financial Officer | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-08-01 | Scienture Holdings, Inc. | Pharmaceuticals | $3,000,000 | $1,715,000 | 8 | 2 |
| 2024-12-19 | Scienture Holdings, Inc. | Pharmaceuticals | $3,333,333 | $3,333,333 | 2 | 1 |
| 2019-08-08 | TRXADE GROUP, INC. | Pharmaceuticals | $2,000,000 | $1,000,000 | 1 | 1 |
| 2018-11-14 | TRXADE GROUP, INC. | Pharmaceuticals | $1,000,000 | $500,000 | 1 | 1 |
| 2018-10-25 | TRXADE GROUP, INC. | Pharmaceuticals | $300,000 | $300,000 | 1 | 1 |
| 2018-07-13 | TRXADE GROUP, INC. | Pharmaceuticals | $2,000,000 | $300,000 | 2 | 1 |
| 2017-03-21 | TRXADE GROUP, INC. | Pharmaceuticals | $250,875 | $250,875 | 1 | 1 |
| 2017-01-17 | TRXADE GROUP, INC. | Pharmaceuticals | $15,000 | $0 | 1 | 1 |
| 2015-11-03 | TRXADE GROUP, INC. | Pharmaceuticals | $1,505,000 | $451,600 | 1 | 1 |
| 2014-10-21 | TRXADE GROUP, INC. | Pharmaceuticals | $2,000,000 | $1,100,000 | 3 | 1 |
| 2014-08-27 | TRXADE GROUP, INC. | Pharmaceuticals | $375,000 | $375,000 | 5 | 1 |
| 2014-08-26 | TRXADE GROUP, INC. | Pharmaceuticals | $64,900,000 | $64,900,000 | 28 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | SCIENTURE HOLDINGS, INC. | State business registries | name and state | |
| Form D issuer | Scienture Holdings, Inc. | Form D private offerings | CIK (EXACT) | |
| SEC filer | Scienture Holdings, Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.